...
首页> 外文期刊>CNS & neurological disorders drug targets >alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: A microdialysis approach.
【24h】

alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: A microdialysis approach.

机译:α-突触核蛋白和MPTP生成的帕金森氏病啮齿动物模型和细胞外纹状体多巴胺动力学研究:一种微透析方法。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The classical animal models of Parkinson's disease (PD) rely on the use of neurotoxins, including 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine and, more recently, the agricultural chemicals paraquat and rotenone, to deplete dopamine (DA). These neurotoxins elicit motor deficits in different animal species although MPTP fails to induce a significant dopaminergic neurodegeneration in rats. In the attempt to better reproduce the key features of PD, in particular the progressive nature of neurodegeneration, alternative PD models have been developed, based on the genetic and neuropathological links between -synuclein ( -syn) and PD. In vivo microdialysis was used to investigate extracellular striatal DA dynamics in MPTP- and -syn-generated rodent models of PD. Acute and sub-acute MPTP intoxication of mice both induce prolonged release of striatal DA. Such DA release may be considered the first step in MPTP-induced striatal DA depletion and nigral neuron death, mainly through reactive oxygen species generation. Although MPTP induces DA reduction, neurochemical and motor recovery starts immediately after the end of treatment, suggesting that compensatory mechanisms are activated. Thus, the MPTP mouse model of PD may be unsuitable for closely reproducing the features of the human disease and predicting potential long-term therapeutic effects, in terms of both striatal extracellular DA and behavioral outcome. In contrast, the -syn-generated rat model of PD does not suffer from a massive release of striatal DA during induction of the nigral lesion, but rather is characterized by a prolonged reduction in baseline DA and nicotine-induced increases in dialysate DA levels. These results are suggestive of a stable nigrostriatal lesion with a lack of dopaminergic neurochemical recovery. The -syn rat model thus reproduces the initial stage and slow development of PD, with a time-dependent impairment in motor function. This article will describe the above experimental PD models and demonstrate the utility of microdialysis for their characterization.
机译:帕金森氏病(PD)的经典动物模型依赖于神经毒素的使用,包括1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP),6-羟基多巴胺以及最近的农用化学品百草枯和鱼藤酮可消耗多巴胺(DA)。尽管MPTP不能在大鼠中引起明显的多巴胺能神经退行性变,但这些神经毒素在不同的动物物种中引起运动缺陷。为了更好地重现PD的关键特征,特别是神经退行性疾病的进展性质,基于-synuclein(-syn)和PD之间的遗传和神经病理学联系,已经开发了替代的PD模型。体内微透析用于研究MPTP和-syn生成的PD啮齿动物模型中细胞外纹状体DA动力学。小鼠的急性和亚急性MPTP中毒均可诱导纹状体DA的延长释放。此类DA释放可能被认为是MPTP诱导的纹状体DA消耗和黑质神经元死亡的第一步,主要是通过活性氧的产生。尽管MPTP诱导DA减少,但是神经化学和运动恢复在治疗结束后立即开始,这表明补偿机制被激活。因此,就纹状体细胞外DA和行为结果而言,PD的MPTP小鼠模型可能不适合紧密复制人类疾病的特征并预测潜在的长期治疗效果。相比之下,-syn生成的PD大鼠模型在诱导黑斑病变期间并未遭受纹状体DA的大量释放,而是其特征在于基线DA的持续降低和尼古丁引起的透析液DA水平的升高。这些结果表明稳定的黑质纹状体病变,缺乏多巴胺能神经化学恢复。因此,-syn大鼠模型再现了PD的初始阶段和缓慢发展,运动功能随时间而变。本文将描述上述实验性PD模型,并演示微透析对其表征的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号